Oncoantigen

#	Item
1	Shionogi Enters into Exclusive Licensing Agreement with OncoTherapy Science to Develop and Market Cancer Peptide Vaccines Osaka, Japan, March 30, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Tes Add to Reading List Source URL: shionogi616.tew-staging.com Language: English Shionogi Immunology Vaccine Oncoantigen Peptide Cancer Medicine Health Vaccination
2	PDF Document Add to Reading List Source URL: www.capconcorp.com Language: English - Date: 2014-12-04 10:38:20 Immunotherapy Immune system Carcinogenesis Cancer immunotherapy Oncoantigen Medicine Immunology Cancer treatments
3	De Giovanni et al. Breast Cancer Research 2014, 16:R10 http://breast-cancer-research.com/content/16/1/R10 Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Vaccination Tyrosine kinase receptors Monoclonal antibodies Cell lines Oncoantigen HER2/neu Trastuzumab DNA vaccination Breast cancer Medicine Biology Immunology